UCDCCC NCTN U10 Program

UCDCCC NCTN U10 项目

• 批准号: 8605734
• 负责人: DAVID R GANDARA
• 金额: $ 70.03万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-14 至 2019-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8605734
• 关键词: Address; American College of Radiology Imaging Network; American College of Surgeons Oncology Group; Area; Awareness; Basic Science; Biometry; California; Cancer Center; Cancer Control; Cancer Patient; Catchment Area; Center for Translational Science Activities; Clinical; Clinical Investigator; Clinical Nursing Research; Clinical Research; Clinical Trials; Clinical Trials Network; Coal; Collaborations; Communities; Comprehensive Cancer Center; Ensure; Faculty; Funding; Genomics; Goals; Gynecologic Oncology Group; Health; Human; Image; Intervention; Laboratories; Lead; Leadership; Link; Malignant Neoplasms; Medical Oncology; Minority; Mission; Molecular Biology; National Cancer Institute; Pathology; Patients; Performance; Play; Population; Principal Investigator; Radiation Oncology; Radiation Therapy Oncology Group; Radiology Specialty; Research Activity; Research Infrastructure; Research Personnel; Research Support; Resources; Role; Rural; Schools; Site; Southwest Oncology Group; Structure; Surgical Specialties; The Jackson Laboratory; Translational Research; Translations; United States National Institutes of Health; Universities; Veterinary Medicine; Xenograft procedure; acronyms; base; cancer care; cancer prevention; career development; comparative; design; experience; improved; innovation; laboratory facility; medical specialties; multidisciplinary; oncology program; outreach; patient population; programs; public health relevance; research study; tertiary care; tumor

DESCRIPTION (provided by applicant): As the only NCI-designated cancer center for inland Northern California's approximately 6 million people, the UC Davis Comprehensive Cancer Center (UCDCCC) provides both primary cancer cares to a large and growing population, and serves as the tertiary referral center for specialty cancer care for the region. For this applicatin to become a NCTN Network Lead Academic Participating Site, led by Drs. David R Gandara, MD, and Richard K Valicenti, MD UCDCCC will leverage an already established multidisciplinary team of cancer investigators from medical oncology, radiation oncology, surgical specialties, molecular biology/genomics, pathology, radiology, biostatistics, research nursing, and clinical research support to provide clinical trials expertise, scientific and administrative leadership and accrual in NCTN studies across a broad range of tumor types and throughout the cooperative group network. UCDCCC and its faculty have a long-standing and proven track record of impactful contribution to national cooperative group activities, including SWOG, RTOG, GOG, ACRIN, and ACOSOG, as well as to other NCI-related committees and initiatives. Expanding this effort to the NCTN concept will increase both the scope and reach of participation, including integrating additional researchers and providing career development opportunities for new faculty and junior investigators. Continuing a strong track record in cooperative group translational and clinical research leadership, UCDCCC is poised to exploit unique institutional strengths in serving as a laboratory resource for cooperative group trials and contributing to hypothesis-driven clinical research. Based on over two decades of already serving as the clinical trials "hub" for accrual to NCI-sponsored studies throughout North-Central California, expansion to the NCTN creates a number of additional opportunities for UCDCCC to both increase main site accrual and to extend access to NCTN trials into the community through the UCDCCC Cancer Care Network and affiliate site, which includes substantial underserved, rural and minority patient populations. In summary, UCDCCC represents an interdisciplinary organizational and leadership structure linked to a clinical trials program that will achieve the coals of the NCTN and ensure robust accrual.

描述（由申请人提供）：加州大学戴维斯分校综合癌症中心（UCDCCC）是唯一一个为北加州内陆约600万人指定的nci癌症中心，为大量不断增长的人口提供初级癌症治疗，并作为该地区专业癌症治疗的三级转诊中心。为了使该应用程序成为NCTN网络领先学术参与站点，由博士领导。医学博士David R Gandara和医学博士Richard K Valicenti UCDCCC将利用已经建立的多学科癌症研究团队，包括医学肿瘤学、放射肿瘤学、外科专业、分子生物学/基因组学、病理学、放射学、生物统计学、研究护理和临床研究支持，提供临床试验专业知识。在广泛的肿瘤类型和整个合作小组网络的NCTN研究中的科学和行政领导和累积。UCDCCC及其教职员工长期以来一直为国家合作小组活动做出有影响力的贡献，包括SWOG， RTOG， GOG， ACRIN和ACOSOG，以及其他nci相关委员会和倡议。将这一努力扩展到NCTN概念将增加参与的范围和范围，包括整合更多的研究人员，并为新教员和初级研究人员提供职业发展机会。UCDCCC在合作小组转化和临床研究领导方面继续保持着良好的记录，准备利用独特的机构优势，作为合作小组试验的实验室资源